Abstract
The effect of a naturally occurring flavonoid apigenin on the development of bombesin-enhanced peritoneal metastasis from intestinal adenocarcinomas induced by azoxymethane was investigated in male Wistar rats. From the start of the experiment, rats were given weekly s.c. injections of azoxymethane (7.4 mg/kg body weight) for 10 weeks and s.c. injection of bombesin (40 μg/kg body weight) every other day, and from week 16, s.c. injections of apigenin (0.75 or 1.5 mg/kg body weight) every other day until the end of the experiment in week 45. Bombesin significantly increased the incidence of intestinal tumors and cancer metastasis to the peritoneum in week 45. It also significantly increased the labeling index of intestinal cancers. Although administration of apigenin at either dose with bombesin had little or no effect on the enhancement of intestinal carcinogenesis by bombesin, the location, histologic type, depth of involvement, infiltrating growth patterns and labeling index, it was found to decrease significantly the incidence of cancer metastasis. Apigenin significantly decreased the incidence of lymphatic vessel invasion of adenocarcinomas, which was enhanced by bombesin. In vitro experiments revealed that apigenin inhibited bombesin-enhanced phosphorylation of mitogen-activated protein kinase (MAPK), but not matrix metalloprotease (MMP)-9 expression. Our findings indicate that apigenin inhibits cancer metastasis through inhibition of phosphorylation of MAPK.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Iishi H, Tatsuta M, Baba M et al. Genistein attenuates peritoneal metastasis of azoxymethane-induced intestinal adenocarcinomas in Wistar rats. Int J Cancer 2000; 86: 416–20.
Fotsis T, Pepper MS, Aktas E et al. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res 1997; 57: 2916–21.
Fotsis T, Pepper MS, Montesano R et al. Phytaestrogens and inhibition of angiogenesis. Baillieres Clin Endocrinol Metab 1998; 12: 649–66.
Iishi H, Tatsuta M, Baba M et al. Enhancement by bombesin of colon carcinogenesis and metastasis induced by azoxymethane in Wistar rats. Int J Cancer 1992; 50: 834–9.
Iishi H, Tatsuta M, Baba M et al. Ornithine decarboxylase inhibitor attenuates bombesin enhancement of intestinal carcinogenesis and metastasis induced by azoxymethane. Int J Cancer 1994; 58: 533–7.
Japanese Research Society for Cancer of the Colon and Rectum. General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus, 6th ed. Tokyo: Kanahara Shoten 1998.
Liao G, Zhang Y, Shen M et al. Significance of proliferating cell nuclear antigen expression in liver metastasis of colorectal cancer. Dis Colon Rectum 1997; 40: 1489–93.
Reddy KB, Krueger JS, Kondapaka SB et al. Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-6) in breast epithelial cells. Int J Cancer 1997; 82: 268–73.
Siegel S. Nonparametric Statistics for the Behavioral Sciences. New York: McGraw-Hill 1956.
Miller RG Jr. Simultaneous Statistical Inference. New York: McGraw-Hill 1966.
Czeczot H, Tudek B, Kusztzelak J et al. Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs. Mutat Res 1990; 240: 209–16.
McVean M, Xiao H, Isobe K et al. Increase in wild-type p53 stability and transactivational activity by the chemopreventive agent apigenin in keratinocytes. Carcinogenesis 2000; 21: 633–9.
Chaumontet C, Droumaguet C, Bex V et al. Flavonoid (apigenin, tangeretin) counteract tumor promoter-induced inhibition of intercellular communication of rat liver epithelial cells. Cancer Lett 1997; 114: 207–10.
Birt DF, Mitchel DL, Gold B et al. Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer Res 1997; 17: 85–92.
Rozengurt E. Signal transduction pathways in the mitogenic response to G protein-coupled neuropeptide receptor agonist. J Cell Physiol 1998; 177: 507–17.
Oka H, Chatani Y, Hoshino R et al. Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res 1995; 55: 4182–7.
Sivaraman VS, Wang H, Nuovo GJ et al. Hyperexpression of mitogen-activated protein kinase in human breast cancer. J Clin Invest 1997; 99: 1478–83.
Sato H, Takino T, Okada Y et al. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature (London) 1994; 370: 61–5.
Ree AH, Bjornland K, Brunner N et al. Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells. Clin Exp Metastasis 1998; 16: 205–15.
Festuccia C, Guerra F, D'Ascenzo S et al. In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin. Int J Cancer 1998; 74: 418–31.
Klemke RL, Cai S, Giannini AL et al. Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 1997; 137: 481–92.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tatsuta, M., Iishi, H., Baba, M. et al. Suppression by apigenin of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats. Clin Exp Metastasis 18, 657–662 (2000). https://doi.org/10.1023/A:1013133803806
Issue Date:
DOI: https://doi.org/10.1023/A:1013133803806